Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 8 years or older.
- The patient, or an adult acting on their behalf, must be able to speak and read English.
- People who have been diagnosed with a specific type of lymphoma called nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), confirmed through a tissue test — including those whose lymphoma has changed (transformed) into another type either at diagnosis or later on.
- The patient, or an adult acting on their behalf, must be able to give consent to participate.
- The patient, or an adult acting on their behalf, must be able to complete online quality of life surveys.
Who may not be able to join:
- People aged 7 years or younger.
- People where neither the patient nor an adult acting on their behalf can speak and read English.
- People diagnosed with a "composite lymphoma" — meaning NLPHL was found at the same time as another type of lymphoma, such as classical Hodgkin lymphoma, indolent non-Hodgkin lymphoma, or gray zone lymphoma.
- People where the patient or their legal guardian is unable or unwilling to give consent.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Valerie Crabtree, PhD, St. Jude Children's Research Hospital
Phone: 888-226-4343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Estimates of response rates; Patterns of individual per-patient survey completion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.